499794-58-0 Usage
Uses
Used in Pharmaceutical Industry:
(S)-3-amino-3-(3-nitrophenyl)propanoic acid hydrochloride is used as an intermediate in the synthesis of pharmaceutical drugs for its potential to contribute to the development of new medications. Its specific properties and reactivity make it a valuable compound in drug discovery and design.
Used in Chemical Research and Development:
In the field of chemical research and development, (S)-3-amino-3-(3-nitrophenyl)propanoic acid hydrochloride serves as a key compound for exploring new chemical reactions and creating novel chemical entities. Its versatility in reacting with other molecules and its structural features allow for the expansion of the chemical space in research endeavors.
Used in Synthesis of Bioactive Molecules:
(S)-3-amino-3-(3-nitrophenyl)propanoic acid hydrochloride is also utilized as a building block in the synthesis of bioactive molecules, which could have applications in various therapeutic areas, including but not limited to, the treatment of diseases and disorders.
Used in Analytical Chemistry:
(S)-3-amino-3-(3-nitrophenyl)propanoic acid hydrochloride can be employed in analytical chemistry as a reference material or a component in the development of new analytical methods, taking advantage of its distinct chemical and physical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 499794-58-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,9,7,9 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 499794-58:
(8*4)+(7*9)+(6*9)+(5*7)+(4*9)+(3*4)+(2*5)+(1*8)=250
250 % 10 = 0
So 499794-58-0 is a valid CAS Registry Number.
499794-58-0Relevant academic research and scientific papers
MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS
-
Page/Page column 154, (2008/06/13)
The present invention relates generally to novel macrocycles of Formula (I): or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, thereof, wherein the variables A, B, L, M, W, Z, R1, R2, R3, R4, R5, R6, R7, R8, R9, and R10 are as defined herein. These compounds are selective inhibitors of the serine protease coagulation factor VIIa which can be used as medicaments.
